cyclosporine has been researched along with Urinary Bladder Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiguro, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Miyamoto, Y; Netto, GJ; Zheng, Y | 1 |
| Ide, H; Ishiguro, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Miyamoto, Y; Netto, GJ; Zheng, Y | 1 |
| Chueh, SC; Chung, SD; Lai, MK; Liao, CH; Wang, SM; Yu, HJ | 1 |
| Lin, J; Tian, Y; Wang, YH; Zhang, YH | 1 |
| Chen, YT; Cheng, YT; Chiang, CY; Hsieh, HH; Wang, HB | 1 |
| Arao, S; Fukumoto, M; Hiai, H; Hirai, M; Kakehi, Y; Kim, WJ; Yoshida, O | 1 |
| Bishop, MC; Dennis, MJ; Ryan, JJ | 1 |
| Benisovich, VI; Cohen, E; Silverman, L; Slifkin, R; Stone, N | 1 |
| Inoue , K; Kawahito, Y; Sano, H; Yoshikawa, T | 1 |
| Mimata, H; Miyamoto, E; Nomura, T; Nomura, Y; Shibasaki, F; Shitashige, M; Yamamoto, H | 1 |
| Keller, F; Offermann, G; Schwarz, A | 1 |
| Mochizuki, T; Nemoto, R; Okabe, K; Satou, S | 1 |
1 review(s) available for cyclosporine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Cisplatin-based chemotherapy in renal transplant recipients. A case report and a review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cyclosporine; Doxorubicin; Humans; Kidney; Kidney Transplantation; Male; Methotrexate; Postoperative Period; Urinary Bladder Neoplasms; Vinblastine | 1996 |
11 other study(ies) available for cyclosporine and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Cyclosporine; Gene Expression Regulation, Neoplastic; Humans; Methylcholanthrene; Mice; Mice, Inbred NOD; Mice, SCID; NFATC Transcription Factors; Signal Transduction; Tacrolimus; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclosporine; Down-Regulation; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; NFATC Transcription Factors; Tacrolimus; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Urothelial carcinoma in kidney transplant recipients: conversion from calcineurin inhibitor to proliferation signal inhibitor?
Topics: Calcineurin Inhibitors; Cell Proliferation; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Postoperative Care; Signal Transduction; Sirolimus; Urinary Bladder Neoplasms | 2008 |
[Proliferation effects of sirolimus, cyclosporine A and mycophenolate mofetil on human transitional cell carcinoma cells].
Topics: Animals; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Humans; Mice; Mice, Nude; Mycophenolic Acid; Sirolimus; Urinary Bladder Neoplasms | 2012 |
The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients.
Topics: Adult; Azathioprine; Carcinoma, Transitional Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Neoplasms, Second Primary; Postoperative Complications; Retrospective Studies; Urinary Bladder Neoplasms | 2002 |
Multidrug resistance-associated protein-mediated multidrug resistance modulated by cyclosporin A in a human bladder cancer cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Biological Transport; Cell Nucleus; Cyclosporine; Daunorubicin; DNA Primers; DNA Topoisomerases, Type I; Drug Resistance, Multiple; Gene Expression; Humans; Molecular Sequence Data; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1995 |
Renal transplantation in a patient with multifocal transitional cell carcinoma.
Topics: Carcinoma, Transitional Cell; Cyclosporine; Humans; Immunosuppression Therapy; Kidney Neoplasms; Kidney Transplantation; Male; Middle Aged; Nephrectomy; Urinary Bladder Neoplasms | 1993 |
What is proper treatment for Wegener granulomatosis?
Topics: Adult; Cyclophosphamide; Cyclosporine; Cystitis; Disease Progression; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Neural Tube Defects; Recurrence; Treatment Refusal; Urinary Bladder Neoplasms | 2001 |
Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzimidazoles; Calcineurin Inhibitors; Caspase 3; Caspases; Cyclosporine; Drug Synergism; Enzyme Activation; Humans; Immunosuppressive Agents; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Staining and Labeling; Tacrolimus; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Analgesic nephropathy and renal transplantation.
Topics: Adult; Analgesics; Cyclosporine; Graft Survival; Humans; Kidney Diseases; Kidney Transplantation; Middle Aged; Prognosis; Substance-Related Disorders; Urinary Bladder Neoplasms | 1992 |
Response of MBT-2 bladder carcinoma-induced osteolysis to various agents.
Topics: Alendronate; Animals; Bone Neoplasms; Bone Resorption; Calcitonin; Cyclosporine; Diphosphonates; Female; Mice; Mice, Inbred C3H; Mice, Nude; Neoplasm Transplantation; Omeprazole; Osteoclasts; Osteolysis; Urinary Bladder Neoplasms | 1992 |